BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Sean McCarthy will participate on a panel at the BIO International Convention in San Diego, CA titled "New Models for External Innovation by Pharma"
News | 06. 17. 2008
